Company Description
Antibe Therapeut (OTC: ATBPF) is a publicly traded medicinal and botanical manufacturing company in the Manufacturing sector.
ATBPF stock has declined 48.6% over the past year.
This page provides a comprehensive overview of ATBPF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Antibe Therapeut (ATBPF) stock. Over the past 12 months, the stock has lost 48.6%.
Latest News
Antibe Therapeut has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include fda approval, conferences, earnings. View all ATBPF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ATBPF Company Profile & Sector Positioning
Antibe Therapeut (ATBPF) operates in the Medicinal and Botanical Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.